Xenon Pharmaceuticals Inc (XENE.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|71||Chairman of the Board|
|42||2018||President, Chief Financial Officer, Chief Operating Officer|
|48||2018||Chief Executive Officer, Director|
|2016||Senior Vice President - Drug Discovery|
|54||2012||Senior Vice President of Business and Corporate Development|
- BRIEF-Xenon Pharma, Teva Pharma Terminate Development & License Agreement
- UPDATE 2-Dermira to abandon acne drug, shares crater
- BRIEF-Xenon Advances Second Proprietary Epilepsy Product Into Clinic With Initiation Of Xen901 Phase 1 Clinical Trial
- BRIEF-Xenon Pharmaceuticals Expects To Have Ongoing XEN1101 Phase 1 Clinical Trial Completed By Mid-Year
- BRIEF-Xenon Pharma Says Entered Into Loan And Security Agreement With Silicon Valley Bank